United States
Germany
Japan
United Kingdom
China
MYCN Mutant (R393S), Myc-DDK-tagged ORF clone of Homo sapiens v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) (MYCN) as transfection-ready DNA
| Mutation | R393S |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Mutant ORF Clones
WT1 Mutant (H473R), Myc-DDK-tagged ORF clone of Homo sapiens Wilms tumor 1 (WT1), transcript variant D as transfection-ready DNA
| Mutation | H473R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (L301R), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | L301R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
WT1 Mutant (D464N), Myc-DDK-tagged ORF clone of Homo sapiens Wilms tumor 1 (WT1), transcript variant D as transfection-ready DNA
| Mutation | D464N |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRCA1 Mutant (G484X), Myc-DDK-tagged ORF clone of Homo sapiens breast Cancer, early onset (BRCA1), transcript variant 1 as transfection-ready DNA
| Mutation | G484X |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (L376P), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | L376P |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
BRCA1 Mutant (Q526X), Myc-DDK-tagged ORF clone of Homo sapiens breast Cancer, early onset (BRCA1), transcript variant 1 as transfection-ready DNA
| Mutation | Q526X |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (Q395X), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | Q395X |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (H317R), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | H317R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (C241R), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | C241R |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (A342P), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | A342P |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
ERCC2 Mutant (Q662X), Myc-DDK-tagged ORF clone of Homo sapiens excision repair cross-complementing rodent repair deficiency, complementation group 2 (ERCC2), transcript variant 1 as transfection-ready DNA
| Mutation | Q662X |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (T148P), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | T148P |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MEN1 Mutant (G532C), Myc-DDK-tagged ORF clone of Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant 2 as transfection-ready DNA
| Mutation | G532C |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
MAF Mutant (R288P), Myc-DDK-tagged ORF clone of Homo sapiens v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) (MAF), transcript variant 1 as transfection-ready DNA
| Mutation | R288P |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
活动过滤器
优化搜索结果
Category
Species
Target Symbol
Tags
Mutants
Brands
Pathways
- Ubiquitin mediated proteolysis (412)
- Pathways in cancer (84)
- Prostate cancer (52)
- Colorectal cancer (49)
- Endometrial cancer (49)
- Thyroid cancer (49)
- Wnt signaling pathway (49)
- Basal cell carcinoma (47)
- Adherens junction (46)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (46)
- Focal adhesion (46)
- Leukocyte transendothelial migration (46)
- Melanogenesis (46)
- Pathogenic Escherichia coli infection (46)
- Tight junction (46)
- Nucleotide excision repair (38)
- Chronic myeloid leukemia (32)
- Jak-STAT signaling pathway (30)
- ErbB signaling pathway (26)
- Endocytosis (24)
- Insulin signaling pathway (24)
- T cell receptor signaling pathway (24)
- Pancreatic cancer (10)
- Cell cycle (9)
- Bladder cancer (8)
- Small cell lung cancer (8)
- Glioma (6)
- Melanoma (6)
- Non-small cell lung cancer (6)
- Toll-like receptor signaling pathway (5)
- Chemokine signaling pathway (4)
- MAPK signaling pathway (3)
- Acute myeloid leukemia (2)
- Apoptosis (2)
- Neurotrophin signaling pathway (2)
- Renal cell carcinoma (2)
- TGF-beta signaling pathway (2)
- mTOR signaling pathway (2)
- Amyotrophic lateral sclerosis (ALS) (1)
- Huntington's disease (1)
- p53 signaling pathway (1)
